Sugi Predict

Sugi Predict / Compounds / SCHEMBL4101466

SCHEMBL4101466

SCHEMBL4101466

Cc1cccc(NC(=O)C2CNCCN2c2nc(N)nc3ccc(-c4ccc(C(F)(F)F)cc4)nc23)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MKNK2 Q9HBH9 1/20 0.39
▸ PI4KB Q9UBF8 1/20 0.37
▸ SCN9A Q15858 2/20 0.37
▸ FPR2 P25090 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ LCK P06239 5/20 0.37
▸ KDR P35968 2/20 0.37
▸ JAK3 P52333 2/20 0.37
▸ TEK Q02763 2/20 0.37
▸ MAPK14 Q16539 2/20 0.37
▸ TRPV1 Q8NER1 2/20 0.36
▸ PAX8 Q06710 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ PDE4A P27815 1/20 0.35
▸ PDE4B Q07343 1/20 0.35
▸ PDE4C Q08493 1/20 0.35
▸ PDE4D Q08499 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4118504 0.91 PI4KB (0.39) PI4KBPOLBMAPTLCKKDR
SCHEMBL4708335 0.91 MAPT (0.44) MKNK2PI4KBPOLBMAPTKDR
SCHEMBL4108347 0.89 MKNK1 (0.38) MKNK2PI4KBPOLBMAPTLCK
SCHEMBL4107810 0.88 POLB (0.39) MKNK2PI4KBPOLBMAPTALDH1A1
SCHEMBL4116800 0.87 PI4KB (0.40) PI4KBPOLBMAPTALDH1A1CCNC
SCHEMBL4521469 0.86 PDE4A (0.51) PI4KBPOLBMAPTKDRALDH1A1
SCHEMBL4102550 0.85 POLB (0.38) PI4KBPOLBMAPTALDH1A1PDE4A
SCHEMBL4108734 0.85 PI4KB (0.38) PI4KBPOLBMAPTALDH1A1PDE4A
SCHEMBL4121021 0.85 ALDH1A1 (0.38) PI4KBPOLBMAPTLCKKDR
SCHEMBL4113839 0.85 PDE4A (0.45) PI4KBPOLBMAPTKDRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090264415-A2 PYRIDO(3,2-D)PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR MEDICAL TREATMENT 4 AZA IP NV (BE) 2009-10-22 — — US disclosed
US-20090036430-A1 PYRIDO(3,2-D)PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR MEDICAL TREATMENT 4 AZA IP NV (BE) 2009-02-05 — — US disclosed
US-20080004285-A1 PYRIDO(3,2-D)PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR MEDICAL TREATMENT 4 AZA IP NV (BE) 2008-01-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004285-A1 PYRIDO(3,2-D)PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR MEDICAL TREATMENT PNPO, TYMP, PNP MKNK2 3818/4885PI4KB 2347/4885SCN9A 2649/4885
US-20090036430-A1 PYRIDO(3,2-D)PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR MEDICAL TREATMENT PNPO, TYMP, PNP MKNK2 3818/4885PI4KB 2347/4885SCN9A 2649/4885
US-20090264415-A2 PYRIDO(3,2-D)PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR MEDICAL TREATMENT PNPO, TYMP, PNP MKNK2 3818/4885PI4KB 2347/4885SCN9A 2649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.